program_name|program_description|program_objective|program_start_date|program_end_date|campaign_id|campaign_name|campaign_description|campaign_objective|campaign_start_date|campaign_end_date|tactic_id|tactic_description|tactic_type|tactic_send_date|channel_category|channel_name|tactic_status|franchise|brand|indication|vendor|geography|customer_type|customer_specialty|customer_segment|delivery_type|tactic_resend|content_testing|content_testing_level|job_number|subject_line_1|pre_header_1|population_share_1|primary_key_message|secondary_key_message|tertiary_key_message|offer_type_1|offer_link_location_1|offer_link_1|content_tag_1|utm_tag_1|offer_type_2|offer_link_location_2|offer_link_2|content_tag_2|utm_tag_2|offer_type_3|offer_link_location_3|offer_link_3|content_tag_3|utm_tag_3|offer_type_4|offer_link_location_4|offer_link_4|content_tag_4|utm_tag_4|offer_type_5|offer_link_location_5|offer_link_5|content_tag_5|utm_tag_5|program_cost|campaign_cost|tactic_cost|goal_metric_1|goal_metric_value_1|goal_metric_2|goal_metric_value_2|goal_metric_3|goal_metric_value_3|goal_metric_4|goal_metric_value_4|goal_metric_5|goal_metric_value_5|vendor_id_flag|vendor_tactic_id
Program 2018 INI|NA|NA|2018-01-31 00:00:00|2018-12-31 00:00:00|Aptus_2018_Dual_Clinical_Alerts_20180131_5|Aptus 2018 Dual Clinical Alerts||Clinical Verification|2018-01-31 00:00:00|2018-12-31 00:00:00|APT_US-OTZ-18-0106_1_02|Aptus 2018 Dual Clincial Alert 2 PsA & PsO Prescribing Numbers|3rd Party Email|2018-12-30 00:00:00|Digital Push|Email|Ready|Inflammation and Immunology|Otezla|PSA and PSO|Aptus|UNITED STATES OF AMERICA|HEALTH CARE PROVIDER|Other|Pathologists|Single Send|true|false|[]|US-OTZ-18-0106|Starting your patients on Otezla (apremilast)||50|Getting Started|Resource Center|$0 Copay|Visit Website|TOP LEFT CORNER|https://www.otezlapro.com||https://www.otezlapro.com?utm_linklocation=TOP%20RIGHT%20CORNER&utm_tacticid=APT_US-OTZ-18-0106_1_02&utm_celgeneid=celg_1234|Web Link|TOP RIGHT CORNER|http://media.celgene.com/content/uploads/otezla-pi.pdf||http://media.celgene.com/content/uploads/otezla-pi.pdf?utm_linklocation=TOP%20LEFT%20CORNER&utm_tacticid=APT_US-OTZ-18-0106_1_01&utm_celgeneid=celg_1234|\N|\N|\N|\N|\N|\N|\N|\N|\N|\N|\N|\N|\N|\N|\N|500|500|500|Open Rate|10|\N|\N|\N|\N|\N|\N|\N|\N|true|M300664
Program 2018 INI|NA|NA|2018-01-31 00:00:00|2018-12-31 00:00:00|Aptus_2018_Dual_Clinical_Alerts_20180131_5|Aptus 2018 Dual Clinical Alerts||Clinical Verification|2018-01-31 00:00:00|2018-12-31 00:00:00|APT_US-OTZ-18-0106_1_01|Aptus 2018 Dual Clincial Alert 2 PsA & PsO Prescribing Numbers|3rd Party Email|2018-12-28 00:00:00|Digital Push|Email|Ready|Inflammation and Immunology|Otezla|PSA and PSO|Aptus|UNITED STATES OF AMERICA|HEALTH CARE PROVIDER|Other|Pathologists|Single Send|true|false|[]|US-OTZ-18-0106|Savings and access info for Otezla apremilast||50|Getting Started|Resource Center|$0 Copay|Visit Website|TOP LEFT CORNER|https://www.otezlapro.com||https://www.otezlapro.com?utm_linklocation=TOP%20RIGHT%20CORNER&utm_tacticid=APT_US-OTZ-18-0106_1_02&utm_celgeneid=celg_1234|Web Link|TOP RIGHT CORNER|http://media.celgene.com/content/uploads/otezla-pi.pdf||http://media.celgene.com/content/uploads/otezla-pi.pdf?utm_linklocation=TOP%20LEFT%20CORNER&utm_tacticid=APT_US-OTZ-18-0106_1_01&utm_celgeneid=celg_1234|\N|\N|\N|\N|\N|\N|\N|\N|\N|\N|\N|\N|\N|\N|\N|500|500|500|Open Rate|10|\N|\N|\N|\N|\N|\N|\N|\N|true|M300662
